Tetsu Tomonari

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima et al. · Liver Cancer · 2023 · 144 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

Masaki Maeda, Issei Saeki, Isao Sakaida et al. · Liver Cancer · 2019 · 81 citations · Full text

Medicine, Oncology, Surgery +13

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma

Tetsu Tomonari, Shunsaku Takeishi, Tatsuya Taniguchi et al. · Oncotarget · 2016 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs

Jinsei Miyoshi, Hiroshi Miyamoto, Takahiro Goji et al. · Journal of Gastroenterology and Hepatology · 2015 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib

Tetsu Tomonari, Yasushi Sato, Hironori Tanaka et al. · Medicine · 2020 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17